86 results
424B5
ATXI
Avenue Therapeutics Inc
10 May 24
Prospectus supplement for primary offering
4:52pm
://www.sec.gov. You can also obtain copies of materials we file with the SEC from our Internet website found at www.avenuetx.com. Our stock is quoted
DEFA14A
ATXI
Avenue Therapeutics Inc
3 May 24
Additional proxy soliciting materials
6:03pm
Additional Materials
Soliciting Material under §240.14a-12
AVENUE THERAPEUTICS, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person … with preliminary materials.
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11
8-K
EX-10.1
ATXI
Avenue Therapeutics Inc
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
as the Company was required by law or regulation to file such material) (the foregoing materials, including the exhibits thereto and documents incorporated
DEF 14C
ATXI
Avenue Therapeutics Inc
18 Mar 24
Information statement
4:59pm
Fee (Check the appropriate box):
No fee required.
Fee paid previously with preliminary materials.
Fee computed on table in exhibit required by Item … stockholders.
HOUSEHOLDING OF STOCKHOLDER MATERIALS
Some bank, brokerage firm or other nominee record holders may be participating in the practice
PRE 14C
bj1lk2d1z36a2l u3
8 Mar 24
Preliminary information
4:31pm
DEF 14C
ihstiv1m6o
29 Jan 24
Information statement
8:00am
PRE 14C
clvhh
17 Jan 24
Preliminary information
5:05pm
8-K
EX-10.2
1k6715tqqm33y
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-10.1
au6p 6qvxj6t8m6
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-10.1
qge kks0r7u
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-10.2
123o gyu1tts
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
DEFA14A
4qc3ai3ggwi5ul6
28 Apr 23
Additional proxy soliciting materials
4:15pm